Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Mochida claims new formulation for ulinastatin

Jan. 20, 1997

Takeda claims new approach to diabetes Rx

Jan. 20, 1997

Troglitazone price-listed in Japan

Jan. 20, 1997

New amylin antagonists from Amylin

Jan. 20, 1997

More antiobesity proteins in the pipeline at Lilly

Jan. 20, 1997

New ACAT inhibitors claimed by DuPont Merck

Jan. 20, 1997

MacroChem to begin clinical trials of SEPA-testosterone

Jan. 17, 1997

AI-401 clinical trial program updated

Jan. 17, 1997

Terrapin, Sanwa establish diabetes R&D collaboration

Jan. 17, 1997

Cortecs signs first European licensing agreement for oral calcitonin

Jan. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...